ENTITY

Vaxcell-Bio Therapeutics (323990 KS)

Analysis

Health Care • South Korea

Vaxcell-Bio Therapeutics, Co. Ltd operates pharmaceutical development businesses. The Company develops anti-cancer drugs, cellular drugs, immune drugs, and other medicines. Vaxcell-Bio Therapeutics conducts businesses in South Korea.

Refresh

No events found

We’ll display events we find for Vaxcell-Bio Therapeutics here

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00